Literature DB >> 24554165

Central hypothyroidism in adults: better understanding for better care.

Solange Grunenwald1, Philippe Caron.   

Abstract

Central hypothyroidism (CH) is a rare cause of hypothyroidism generally related to a hypothalamic-pituitary disorder or arising as an iatrogenic complication. In adults, CH may be secondary to quantitative and/or qualitative alterations in thyroid-stimulating hormone (TSH) secretion. The disease is difficult to diagnose clinically because it lacks specific clinical signs and these may be masked by other anterior pituitary hormone secretion deficiencies. In patients with long-standing and marked CH, a diagnosis may be made based on low free T4 levels and normal, low or moderately increased TSH levels. In patients with early-stage or moderate CH, exploration of the circadian TSH cycle, determination of TSH response after a TRH test or recombinant TSH injection, estimation of TSH index, or evaluation of peripheral indexes of thyroid hormone metabolism may be required to establish a diagnosis. Regarding treatment, patients should receive levothyroxine replacement therapy, but hormone objectives during follow-up need to be precisely determined in order to reduce cardiovascular risks and to improve the quality of life of patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24554165     DOI: 10.1007/s11102-014-0559-8

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  57 in total

1.  Thyreotropin levels in diabetic patients on metformin treatment.

Authors:  Carlo Cappelli; Mario Rotondi; Ilenia Pirola; Barbara Agosti; Annamaria Formenti; Emanuela Zarra; Umberto Valentini; Paola Leporati; Luca Chiovato; Maurizio Castellano
Journal:  Eur J Endocrinol       Date:  2012-05-29       Impact factor: 6.664

2.  Usefulness of thyrotropin (TSH)-releasing hormone test and nocturnal surge of TSH for diagnosis of isolated deficit of TSH secretion.

Authors:  N Yamakita; T Komaki; T Takao; T Murai; K Hashimoto; K Yasuda
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

3.  Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.

Authors:  E Ferretti; L Persani; M L Jaffrain-Rea; S Giambona; G Tamburrano; P Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

4.  Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone.

Authors:  P Beck-Peccoz; S Amr; M M Menezes-Ferreira; G Faglia; B D Weintraub
Journal:  N Engl J Med       Date:  1985-04-25       Impact factor: 91.245

5.  Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus.

Authors:  A Alkemade; U A Unmehopa; W M Wiersinga; D F Swaab; E Fliers
Journal:  J Clin Endocrinol Metab       Date:  2004-10-27       Impact factor: 5.958

6.  Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia.

Authors:  Tetsuya Tagami; Hironori Kimura; Sumire Ohtani; Tsuyoshi Tanaka; Takashi Tanaka; Shiro Hata; Miho Saito; Yasushi Miyazaki; Rika Araki; Masami Tanaka; Kazuya Yonezawa; Morio Sawamura; Takuyuki Ise; Atsushi Ogo; Takuro Shimbo; Akira Shimatsu; Mitsuhide Naruse
Journal:  Endocr J       Date:  2011-04-20       Impact factor: 2.349

Review 7.  Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity.

Authors:  L Persani
Journal:  Thyroid       Date:  1998-10       Impact factor: 6.568

8.  Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

Authors:  Miguel López; Luis Varela; María J Vázquez; Sergio Rodríguez-Cuenca; Carmen R González; Vidya R Velagapudi; Donald A Morgan; Erik Schoenmakers; Khristofor Agassandian; Ricardo Lage; Pablo Blanco Martínez de Morentin; Sulay Tovar; Rubén Nogueiras; David Carling; Christopher Lelliott; Rosalía Gallego; Matej Oresic; Krishna Chatterjee; Asish K Saha; Kamal Rahmouni; Carlos Diéguez; Antonio Vidal-Puig
Journal:  Nat Med       Date:  2010-08-29       Impact factor: 53.440

Review 9.  Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values.

Authors:  Nieke E Kokshoorn; Moniek J E Wassenaar; Nienke R Biermasz; Ferdinand Roelfsema; Johannes W A Smit; Johannes A Romijn; Alberto M Pereira
Journal:  Eur J Endocrinol       Date:  2009-09-25       Impact factor: 6.664

10.  Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.

Authors:  J O Jørgensen; J Møller; T Laursen; H Orskov; J S Christiansen; J Weeke
Journal:  Clin Endocrinol (Oxf)       Date:  1994-11       Impact factor: 3.478

View more
  4 in total

Review 1.  Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-09-06       Impact factor: 3.633

Review 2.  Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

Review 3.  Central hypothyroidism - a neglected thyroid disorder.

Authors:  Paolo Beck-Peccoz; Giulia Rodari; Claudia Giavoli; Andrea Lania
Journal:  Nat Rev Endocrinol       Date:  2017-05-26       Impact factor: 43.330

4.  Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea.

Authors:  Nanfang Li; Mulalibieke Heizhati; Chao Sun; Suofeiya Abulikemu; Liang Shao; Xiaoguang Yao; Yingchun Wang; Jing Hong; Ling Zhou; Lei Wang; Yu Zhang; Weiwei Zhang
Journal:  Int J Endocrinol       Date:  2016-11-02       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.